TRIALS UPDATE: Our Q2 Roundup of Alzheimer’s Clinical Trials News
In a recent survey, Being Patient put a question to readers: “What is the biggest barrier preventing you from seeking a trial?” The most…
In a recent survey, Being Patient put a question to readers: “What is the biggest barrier preventing you from seeking a trial?” The most…
According to Homer Simpson, alcohol is “the cause of, and solution to, all of life’s problems.” While the patriarch of the Simpson family isn’t…
A new drug for Alzheimer’s was just this month approved by the FDA for use in the United States, in people in the earliest…
By a woman’s late 40s, there is a good chance she’ll have started to experience the early phases of menopause. Menopause isn’t just the…
There are more than 500 active clinical trials for Alzheimer’s and other dementias in the U.S. They are designed to test different interventions, such…
UPDATED JULY 3: The Food and Drug Administration has approved Kisunla (generic name donanemab), a new Alzheimer’s drug developed by Eli Lilly. The published data…
Drugmaker Alzheon is currently running clinical trials on a new disease-modifying Alzheimer’s treatment: valiltramiprosate, or ALZ-801. While, like the new buzzy new Alzheimer’s monoclonal…
Here’s the funny thing about Alzheimer’s biomarker blood tests: They can’t actually determine whether or not a person has Alzheimer’s. So what are they…
Alzheimer’s disease affects one in 10 people over the age of 65. One of the strongest genetic risk factors for developing the disease is…
When Alois Alzheimer first described the brains of people with Alzheimer’s disease more than 100 years ago, he spotted the telltale signs of the…
Today, the Food and Drug Administration’s (FDA) eleven-person advisory committee unanimously voted, (11-0) that Eli Lilly’s anti-amyloid Alzheimer’s drug donanemab was effective, and that…
A woman whose husband is living with dementia once told travel expert Catherine Reed that she wanted a vacation, but didn’t want to leave…
While many genes can affect your risk of developing Alzheimer’s, most have a very small effect. The most common gene linked to late-onset Alzheimer’s…
Across Alzheimer’s disease and other dementias, protein plaques and deposits in the brain — like beta-amyloid, tau, and TDP-43 — are linked to inflammation,…
Wildfires, gasoline, oil, and wood fuels release plumes of pollutants that negatively impact lung and brain health. Most of these health risks come from…